Alkermes, Inc. (ALKS)

$8.66 -0.25 (-2.81%)

11/20/2009 4:00 PM

CAPS Rating

Open

$8.89

Previous Close

$8.91

Daily Range

$8.63 - $8.99

52-Week Range

$5.55 - $13.16

Market Cap

$820.67M

P/E Ratio

10.61

Dividend (Yield)

N/A (N/A)

Volume

514,199

Average Daily Volume

859,000

ALKS VS S&P 500 (SPY)

Caps

Motley Fool CAPS is a community working together to find better stocks and to become better investors.

4-Star Stocks Poised to Pop: AlkermesNovember 17, 2009 – The Motley Fool
UPDATE 1-Alkermes says drug meets main goal of late-stage trialNovember 16, 2009 – Reuters
Amylin Scores a Hat TrickNovember 03, 2009 – The Motley Fool
Alkermes Needs Some Financial AlchemySeptember 23, 2009 – The Motley Fool
This Is How You'll Find Value WinnersSeptember 22, 2009 – The Motley Fool
4-Star Stocks on the UpswingSeptember 17, 2009 – The Motley Fool
Elan and J&J, Sitting in a Tree ...August 27, 2009 – The Motley Fool
The Blockbuster Around the CornerJuly 22, 2009 – The Motley Fool
Best of Both WorldsMay 28, 2009 – The Motley Fool
Flip-Flopping: Not Just for Politicians AnymoreMay 19, 2009 – The Motley Fool
5 Magical StocksApril 28, 2009 – The Motley Fool
Cost-Cutting? Check. Increased Sales? Hmm …April 17, 2009 – The Motley Fool
4-Star Stocks on the UpswingApril 03, 2009 – The Motley Fool
Amylin Smacks Down the CompetitionMarch 31, 2009 – The Motley Fool
The Skinny on a Triple-Decker UpdateMarch 27, 2009 – The Motley Fool
The FDA's Bipolar DecisionFebruary 11, 2009 – The Motley Fool
Roses and Candy From the FDA?February 10, 2009 – The Motley Fool
5 Stocks Ready for LiftoffJanuary 21, 2009 – The Motley Fool
FDA Toys With Lilly, and Investors, AgainJanuary 08, 2009 – The Motley Fool
Amylin Gets Some FDA LoveDecember 12, 2008 – The Motley Fool